Biological and In silico Studies on Synthetic Analogues of Tyrosine Betaine as Inhibitors of Neprilysin - A Drug Target for the Treatment of Heart Failure

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|24|17|1899-1904

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.17, 2018-05, pp. : 1899-1904

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Chronic Heart Failure in the Elderly

By Leibundgut Gregor   Pfisterer Matthias   Rocca Hans-Peter Brunner-La  

Drugs & Aging, Vol. 24, Iss. 12, 2007-01 ,pp. : 991-1006

Adis International

Access to resources Recommend Favorite

Drug Treatment of Patients with Decompensated Heart Failure

By Mills R.M.   Hobbs R.E.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of Salicylamide Analogues as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 4, 2016-05 ,pp. : 314-323

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Tumour Necrosis Factor As a Potential Target for the Treatment of Congestive Heart Failure

By Visioli F.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 91-91

Academic Press

Access to resources Recommend Favorite

Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure

By Karmazyn M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 835-843

Informa Healthcare

Access to resources Recommend Favorite